Managing LDL-cholesterol with PCSK9 inhibitors: Identifying the patients, optimizing the outcomes

Authors

Tyler J Gluckman, Providence Heart and Vascular Institute, Portland, OR, USA.Follow

Document Type

Presentation

Publication Date

2-2019

Keywords

cards; cards presentation

Area of Special Interest

Cardiovascular (Heart)

Specialty/Research Institute

Cardiology

Comments

Presented at National lipid Association meeting, Portland, OR